Cargando…

Recent Advances in Superparamagnetic Iron Oxide Nanoparticles for Cellular Imaging and Targeted Therapy Research

Advances of nanotechnology have led to the development of nanomaterials with both potential diagnostic and therapeutic applications. Among them, superparamagnetic iron oxide (SPIO) nanoparticles have received particular attention. Over the past decade, various SPIOs with unique physicochemical and b...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yi-Xiang J., Xuan, Shouhu, Port, Marc, Idee, Jean-Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082310/
https://www.ncbi.nlm.nih.gov/pubmed/23621536
http://dx.doi.org/10.2174/1381612811319370003
_version_ 1782324243022741504
author Wang, Yi-Xiang J.
Xuan, Shouhu
Port, Marc
Idee, Jean-Marc
author_facet Wang, Yi-Xiang J.
Xuan, Shouhu
Port, Marc
Idee, Jean-Marc
author_sort Wang, Yi-Xiang J.
collection PubMed
description Advances of nanotechnology have led to the development of nanomaterials with both potential diagnostic and therapeutic applications. Among them, superparamagnetic iron oxide (SPIO) nanoparticles have received particular attention. Over the past decade, various SPIOs with unique physicochemical and biological properties have been designed by modifying the particle structure, size and coating. This article reviews the recent advances in preparing SPIOs with novel properties, the way these physicochemical properties of SPIOs influence their interaction with cells, and the development of SPIOs in liver and lymph nodes magnetic resonance imaging (MRI) contrast. Cellular uptake of SPIO can be exploited in a variety of potential clinical applications, including stem cell and inflammation cell tracking and intra-cellular drug delivery to cancerous cells which offers higher intra-cellular concentration. When SPIOs are used as carrier vehicle, additional advantages can be achieved including magnetic targeting and hyperthermia options, as well as monitoring with MRI. Other potential applications of SPIO include magnetofection and gene delivery, targeted retention of labeled stem cells, sentinel lymph nodes mapping, and magnetic force targeting and cell orientation for tissue engineering.
format Online
Article
Text
id pubmed-4082310
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-40823102014-07-07 Recent Advances in Superparamagnetic Iron Oxide Nanoparticles for Cellular Imaging and Targeted Therapy Research Wang, Yi-Xiang J. Xuan, Shouhu Port, Marc Idee, Jean-Marc Curr Pharm Des Article Advances of nanotechnology have led to the development of nanomaterials with both potential diagnostic and therapeutic applications. Among them, superparamagnetic iron oxide (SPIO) nanoparticles have received particular attention. Over the past decade, various SPIOs with unique physicochemical and biological properties have been designed by modifying the particle structure, size and coating. This article reviews the recent advances in preparing SPIOs with novel properties, the way these physicochemical properties of SPIOs influence their interaction with cells, and the development of SPIOs in liver and lymph nodes magnetic resonance imaging (MRI) contrast. Cellular uptake of SPIO can be exploited in a variety of potential clinical applications, including stem cell and inflammation cell tracking and intra-cellular drug delivery to cancerous cells which offers higher intra-cellular concentration. When SPIOs are used as carrier vehicle, additional advantages can be achieved including magnetic targeting and hyperthermia options, as well as monitoring with MRI. Other potential applications of SPIO include magnetofection and gene delivery, targeted retention of labeled stem cells, sentinel lymph nodes mapping, and magnetic force targeting and cell orientation for tissue engineering. Bentham Science Publishers 2013-11 2013-11 /pmc/articles/PMC4082310/ /pubmed/23621536 http://dx.doi.org/10.2174/1381612811319370003 Text en © 2013 Bentham Science Publishers http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Wang, Yi-Xiang J.
Xuan, Shouhu
Port, Marc
Idee, Jean-Marc
Recent Advances in Superparamagnetic Iron Oxide Nanoparticles for Cellular Imaging and Targeted Therapy Research
title Recent Advances in Superparamagnetic Iron Oxide Nanoparticles for Cellular Imaging and Targeted Therapy Research
title_full Recent Advances in Superparamagnetic Iron Oxide Nanoparticles for Cellular Imaging and Targeted Therapy Research
title_fullStr Recent Advances in Superparamagnetic Iron Oxide Nanoparticles for Cellular Imaging and Targeted Therapy Research
title_full_unstemmed Recent Advances in Superparamagnetic Iron Oxide Nanoparticles for Cellular Imaging and Targeted Therapy Research
title_short Recent Advances in Superparamagnetic Iron Oxide Nanoparticles for Cellular Imaging and Targeted Therapy Research
title_sort recent advances in superparamagnetic iron oxide nanoparticles for cellular imaging and targeted therapy research
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082310/
https://www.ncbi.nlm.nih.gov/pubmed/23621536
http://dx.doi.org/10.2174/1381612811319370003
work_keys_str_mv AT wangyixiangj recentadvancesinsuperparamagneticironoxidenanoparticlesforcellularimagingandtargetedtherapyresearch
AT xuanshouhu recentadvancesinsuperparamagneticironoxidenanoparticlesforcellularimagingandtargetedtherapyresearch
AT portmarc recentadvancesinsuperparamagneticironoxidenanoparticlesforcellularimagingandtargetedtherapyresearch
AT ideejeanmarc recentadvancesinsuperparamagneticironoxidenanoparticlesforcellularimagingandtargetedtherapyresearch